Intraluminal brachytherapy boost following external beam radiotherapy with concurrent chemotherapy of oesophagus carcinoma: Results of a prospective observational study.
CONCLUSIONS: With the concept that high tumoricidal dose for adequate tumor control achieved by intraluminal brachytherapy as a mean of dose escalation, while sparing surrounding normal tissue and potentially improving therapeutic ratio, external beam radiotherapy followed by intraluminal brachytherapy could be a better choice for oesophagus carcinoma.
PMID: 29615371 [PubMed - as supplied by publisher]
Source: Cancer Radiotherapie - Category: Cancer & Oncology Authors: Nag P, Gurjar OP, Bhandari V, Gupta KL, Bagdare P, Goyal H Tags: Cancer Radiother Source Type: research
More News: Brachytherapy | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Esophagus Cancer | External Beam Therapy | Oesophagus | Study | Toxicology